focus -WSS

focus

author：hotspot 2025-09-06 04:30:25 - browse：41837

Peter Marks. -- health coverage from STAT — Peter Marks, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration. Susan Walsh-Pool/Getty Images

Peter Marks wants drug developers to ask more stupid questions.

It’s part of the top Food and Drug Administration official’s plan to reinvigorate gene therapy, a field that has struggled despite significant technological advances. Some companies are shelving programs or going out of business, even when they have promising data.

The problems are numerous: The diseases are often exceptionally rare, limiting the potential market. Manufacturing at commercial quality is complex and expensive. Proving a drug works can be difficult, because there may be too few patients to run a traditional randomized study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： I learned firsthand about improving diversity in clinical trials

WSS

Air quality improving but still lags in Black, Hispanic communities

Awakening the world to the whoosh: A patient's crusade

Mass General totes up its waste in a move to tackle climate change

Stanford president's case begs question: Who takes blame?

Study identifies new proteins linked to dementia risk 25 years later

Former medical device CEO who sold dummy, plastic parts convicted of fraud

leisure time

focus

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Stanford president's case begs question: Who takes blame?

Psychedelics group wrestles with new pharma identity

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

Bright Health sells Medicare Advantage business to Molina

Just how do doctors, lawmakers, and the public define abortion?

Activists slam private health insurers over coverage restrictions

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

BioMarin wins approval for gene therapy to treat hemophilia A

Just how do doctors, lawmakers, and the public define abortion?

focus

7 more heat

Study identifies new proteins linked to dementia risk 25 years later

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Driven by the pandemic, applicants flood public health schools

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

Mass General totes up its waste in a move to tackle climate change

hotspot

focus

explore

hotspot